Abuse of Synthetic Cannabinoids - "Spice"
Synthetic cannabinoids are the largest and fastest growing group of new psychoactive substances on the market. But, what are synthetic cannabinoids and why do you need to know about them?
Speaker: Pat Pizzo, former member of the Federal Drug Testing Advisory Board (DTAB) and Director of Toxicology, Alere Toxicology Services
This webinar was recorded on August 8, 2017
As new synthetic drugs come on the market, it is critical for problem solving courts, and all those involved with drug testing, to have knowledge about these new drugs, their effects, and how to identify them. Patricia Pizzo (Pat), a former member of the Federal Drug Testing Advisory Board (DTAB), discusses the abuse of synthetic cannabinoids, detection using two new screening immunoassays for criminal justice and forensic use only from Thermo Fisher Scientific, and confirmation testing via mass spectrometry.
Learning Objectives
In this webinar, Pat describes the growing abuse of synthetic cannabinoids, their health risks, prevalence, and available solutions for urine screening. The talk will be followed by an interactive Q&A session that gives you an opportunity to ask questions about synthetic cannabinoids. In the webinar, Pat covers the following:
- What are synthetic cannabinoids?
- How are synthetic cannabinoids abused?
- What are some of the short and long term effects of this new psychoactive drug?
- What are the commonly abused analytes?
- How are they tested?
- What new testing solutions are available?
Speaker: Pat Pizzo, former member of the Federal Drug Testing Advisory Board (DTAB) and Director of Toxicology, Alere Toxicology Services
Who Should Atttend
Criminal Justice Professionals
- Judges
- Drug Court Coordinators
- Drug Testing Personnel
- Case Managers
- Probation/Parole Officers
- Treatment Providers
Reference Labs
- Directors
- Managers/Supervisors
- Lab Assistants
Pain Management Professionals
- Doctors
- Clinical Directors
- Nurses
- Lab Managers/Supervisors
- Lab Assistants
CE credit not available for this webinar.